A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers
Novartis
Novartis
Washington University School of Medicine
Quadriga Biosciences, Inc.
Xencor, Inc.
Scripps Health
Bayer
Abramson Cancer Center at Penn Medicine
Fox Chase Cancer Center
Novartis
INSYS Therapeutics Inc
National Institutes of Health Clinical Center (CC)